Market Place
Sourcing Support
Prokarium Expands IP Portfolio with Bladder Cancer Patents
01 Nov 2024 //
BUSINESSWIRE
Prokarium Achieves Milestone with First Dosing in Invasive Bladder Cancer Trial
07 Feb 2024 //
BUSINESSWIRE
Prokarium Achieves Milestone with FDA`s IND Approval for Bladder Cancer Program
02 Nov 2023 //
BUSINESSWIRE
Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic
09 Feb 2023 //
BUSINESSWIRE
Prokarium raises $30M, pushes new bacteria immunotherapy for bladder cancer
09 Feb 2023 //
ENDPTS
Prokarium & Ginkgo Announce Partnership to Discover Targets for RNA Therapeutics
09 Jan 2023 //
PR NEWSWIRE
Prokarium Strengthens Patent Position Through Notice of Allowance of US Patent
05 Oct 2022 //
BUSINESSWIRE
Prokarium Exercises Option for Excl WW License for Salmonella Immunotherapy
02 Mar 2022 //
BUSINESSWIRE
Prokarium & Wacker Biotech Sign Manufacturing Contract for Bladder Cancer
12 Oct 2021 //
CONTRACTPHARMA
Prokarium Appoints Industry Veteran Thomas Eldered as Chairman of the Board
05 Oct 2021 //
BUSINESSWIRE
Prokarium Appoints Uz Stammberger Medical Director
29 Jul 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.